You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CORDRAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cordran, and what generic alternatives are available?

Cordran is a drug marketed by Almirall and Lilly and is included in five NDAs.

The generic ingredient in CORDRAN is flurandrenolide; neomycin sulfate. There are four drug master file entries for this compound. Additional details are available on the flurandrenolide; neomycin sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CORDRAN?
  • What are the global sales for CORDRAN?
  • What is Average Wholesale Price for CORDRAN?
Summary for CORDRAN
Drug patent expirations by year for CORDRAN
Drug Prices for CORDRAN

See drug prices for CORDRAN

Pharmacology for CORDRAN

US Patents and Regulatory Information for CORDRAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almirall CORDRAN flurandrenolide LOTION;TOPICAL 013790-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almirall CORDRAN SP flurandrenolide CREAM;TOPICAL 012806-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almirall CORDRAN flurandrenolide TAPE;TOPICAL 016455-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almirall CORDRAN SP flurandrenolide CREAM;TOPICAL 012806-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almirall CORDRAN flurandrenolide OINTMENT;TOPICAL 012806-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Almirall CORDRAN flurandrenolide OINTMENT;TOPICAL 012806-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly CORDRAN N flurandrenolide; neomycin sulfate OINTMENT;TOPICAL 050345-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.